
Longevity InTime is a biotech company focused on extending active lifespan by over 20 years through AI and Big Data health monitoring technology. Their platform offers real-time tracking of severe diseases from early stages by measuring over 400 biomarkers via wearable devices, manual inputs, lab tests, and their proprietary BioContainer. They integrate AI simulations for fundamental anti-aging science and combine blockchain, gamification, and medical tourism to engage users. Their ecosystem includes disease prediction apps, AI clinical trial simulations, crypto coins, longevity tourism, and advocacy initiatives. The company operates globally with a team of 50+ professionals from 12 countries and aims to revolutionize personalized health management and longevity through continuous biodata measurement and predictive analytics.

Longevity InTime is a biotech company focused on extending active lifespan by over 20 years through AI and Big Data health monitoring technology. Their platform offers real-time tracking of severe diseases from early stages by measuring over 400 biomarkers via wearable devices, manual inputs, lab tests, and their proprietary BioContainer. They integrate AI simulations for fundamental anti-aging science and combine blockchain, gamification, and medical tourism to engage users. Their ecosystem includes disease prediction apps, AI clinical trial simulations, crypto coins, longevity tourism, and advocacy initiatives. The company operates globally with a team of 50+ professionals from 12 countries and aims to revolutionize personalized health management and longevity through continuous biodata measurement and predictive analytics.
Core focus: AI & Big Data health monitoring for early disease detection and lifespan extension
Measured biomarkers: Claims measurement of 400+ biomarkers via wearables, lab tests, manual input, and proprietary BioContainer
Products: Mobile Disease Tracker app/Telegram bot, AI disease-prediction models, AI clinical-trial simulations
Legal identity: InTime BioTech LLC (doing business as Longevity InTime), registered in Delaware
Founders / leadership: Oleg Teterin listed as CEO; founders listed variously as Oleg Teterin and Roman Dushkin
Early detection and prevention of severe diseases; personalized longevity management
2018
Biotechnology
Crunchbase records associate ALTS Accelerator with a pre-seed investment
2400000
Total funding amount and date reported on company snapshot data
“ALTS Accelerator; company materials list investor opportunities and associate early-stage/pre-seed activity”